Deficient double-strand break repair in oral squamous cell carcinoma cell lines

Journal of Oral Pathology and Medicine

Volumn 46, Issue 9, 2017, Pages 695-702

  Jessri, Maryam ^a   Dalley, Andrew J ^a   Farah, Camile S ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

double strand break repair; dysplasia; oral squamous cell carcinoma; H2Ax

Indexed keywords

ATM PROTEIN; CAMPTOTHECIN; HISTONE H2AX; HYDROGEN PEROXIDE; NIBRIN; DNA;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA REPAIR; DOUBLE STRANDED DNA BREAK; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; KINETICS; MOUTH SQUAMOUS CELL CARCINOMA; ORAL SQUAMOUS CELL CARCINOMA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; GENETICS; MOUTH TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; DNA, NEOPLASM; HUMANS; MOUTH NEOPLASMS;

EID: 85030329846     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12576     Document Type: Article

References (22)

1. Erenpreisa J, Kalejs M, Ianzini F, et al. Segregation of genomes in polyploid tumour cells following mitotic catastrophe. Cell Biol Int. 2005;29:1005-1011.
2. Califano J, vanderRiet P, Westra W, et al. Genetic progression model for head and neck cancer: Implications for field cancerization. Can Res. 1996;56:2488-2492.
3. Haya-Fernandez MC, Bagan JV, Murillo-Cortes J, Poveda-Roda R, Calabuig C. The prevalence of oral leukoplakia in 138 patients with oral squamous cell carcinoma. Oral Dis. 2004;10:346-348.
4. Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med. 2008;37:1-10.
5. Desai SD, Zhang H, Rodriguez-Bauman A, et al. Transcription-dependent degradation of topoisomerase I-DNA covalent complexes. Mol Cell Biol. 2003;23:2341-2350.
6. Lin CP, Ban Y, Lyu YL, Desai SD, Liu LF. A ubiquitin-proteasome pathway for the repair of topoisomerase I-DNA covalent complexes. J Biol Chem. 2008;283:21074-21083.
7. Dalley AJ, Abdulmajeed AA, Upton Z, Farah CS. Organotypic culture of normal, dysplastic and squamous cell carcinoma-derived oral cell lines reveals loss of spatial regulation of CD44 and p75NTR in malignancy. J Oral Pathol Med. 2013;42:37-46.
8. Berndt A, Hyckel P, Konneker A, Katenkamp D, Kosmehl H. Oral squamous cell carcinoma invasion is associated with a laminin-5 matrix re-organization but independent of basement membrane and hemidesmosome formation. clues from an in vitro invasion model. Invasion Metastasis. 1997;17:251-258.
9. Dickson MA, Hahn WC, Ino Y, et al. Human keratinocytes that express hTERT and also bypass a p16(INK4a)- enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol. 2000;20:1436-1447.
10. Chang SE, Foster S, Betts D, Marnock WE. DOK, a cell line established from human dysplastic oral mucosa, shows a partially transformed non-malignant phenotype. Int J Cancer. 1992;52:896-902.
11. Grosse N, Fontana AO, Hug EB, et al. Deficiency in homologous recombination renders mammalian cells more sensitive to proton versus photon irradiation. Int J Radiat Oncol Biol Phys. 2014;88:175-181.
12. Oliveira-Costa JP, Oliveira LR, Zanetti R, et al. BRCA1 and gammaH2AX as independent prognostic markers in oral squamous cell carcinoma. Oncoscience. 2014;1:383-391.
13. Matthaios D, Foukas PG, Kefala M, et al. gamma-H2AX expression detected by immunohistochemistry correlates with prognosis in early operable non-small cell lung cancer. Onco Targets Ther. 2012;5:309-314.
14. Nagelkerke A, van Kuijk SJ, Sweep FC, et al. Constitutive expression of gamma-H2AX has prognostic relevance in triple negative breast cancer. Radiother Oncol. 2011;101:39-45.
15. Brunner AH, Hinterholzer S, Riss P, Heinze G, Weiss K, Brustmann H. Expression of gamma-H2AX in endometrial carcinomas: an immunohistochemical study with p53. Gynecol Oncol. 2011;121:206-211.
16. Chou SJ, Alawi F. Expression of DNA damage response biomarkers during oral carcinogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111:346-353.
17. Lakin ND, Weber P, Stankovic T, Rottinghaus ST, Taylor AMR, Jackson SP. Analysis of the ATM protein in wild-type and ataxia telangiectasia cells. Oncogene. 1996;13:2707-2716.
18. Martin NT, Nakamura K, Davies R, et al. ATM-dependent MiR-335 Targets CtIP and modulates the DNA damage response. PLoS Genet. 2013;9:e1003505.
19. Shimura T, Ochiai Y, Noma N, Oikawa T, Sano Y, Fukumoto M. Cyclin D1 overexpression perturbs DNA replication and induces replication-associated DNA double-strand breaks in acquired radioresistant cells. Cell Cycle. 2013;12:773-782.
20. Kefala M, Papageorgiou SG, Kontos CK, et al. Increased expression of phosphorylated NBS1, a key molecule of the DNA damage response machinery, is an adverse prognostic factor in patients with de novo myelodysplastic syndromes. Leuk Res. 2013;37:1576-1582.
21. Hsu DS, Chang SY, Liu CJ, et al. Identification of increased NBS1 expression as a prognostic marker of squamous cell carcinoma of the oral cavity. Cancer Sci. 2010;101:1029-1037.
22. Amaral-Silva GK, Martins MD, Pontes HA, et al. Mismatch repair system proteins in oral benign and malignant lesions. J Oral Pathol Med. 2017;46:241-245.